Wyeth, Cordis Stent Patents Are Invalid, Fed. Circ. Rules
A three-judge panel held that the patents covering the use of rapamycin to prevent the narrowing of an artery are invalid for lack of enablement because one skilled in the art could not practice the full scope of the patents without undue experimentation.
"There is no genuine...
To view the full article, register now.